Jean-Francois Martini
Company: Pfizer
Job title: Executive Director, Translational Oncology Lead, Global Product Development, Oncology
Seminars:
Developing Scientifically Robust “Surrogate” Endpoints Aligned with Regulatory Expectations to Enhance Clinical Trial Execution 8:45 am
• Current efforts to generate the level of evidence necessary to elevate ctDNA modulation as “surrogate” endpoint • Leveraging liquid biopsies to guide dosage • How to adapt to the changing regulatory environment to integrate new, ctDNA-based, “surrogate” endpoints into clinical trials?Read more
day: Day Two
Chair’s Closing Remarks & End of Conference Day One 5:40 pm
day: Day One
Chair’s Opening Remarks 8:50 am
day: Day One
Equity, Diversity & Inclusion Fireside Chat: Exploiting Liquid Biopsies to Boost Inclusivity in Clinical Trials to Elevate Patient Surveillance & Elevate Survival Rates in Oncology 10:00 am
• How could liquid biopsies provide better precision healthcare surveillance options for patients in economically deprived areas? • How to utilize liquid biopsies to increase diverse populations in clinical trials to ensure comprehensive and equitable outcomes • Analysing the impact of low-cost tests in enhancing the inclusion of diverse populations in clinical studies to improve…Read more
day: Day One